Future studies to further clarify the interaction of these two important transcriptional pathways in HSF1 and MYC, identify actionable therapeutic targets, and disrupt cancer-promoting pathways that could lead to clinical advances in a precision medicine therapeutic approach are warranted. Here, HSF1 is linked to cancer.